Posted in | News | Nanoelectronics

EMC3D Consortium Extends Goals and Program to July 2011

Members of the international EMC3D semiconductor equipment and materials consortium today announced they will extend the life of the joint agreement to July 2011 from an original closing date of October 2009.

The initial goals of the consortium were to bring to market individual unit processes that can be quickly adopted into a volume production environment, and establish a basic understanding of the interactive relationship between process steps, all for a low overall Cost of Ownership (CoO) for 3D chip stacking.

The consortium originally identified a CoO target of $200usd per wafer for a fully processed die-to-wafer 3D stack on 300mm wafers. "Improvements of equipment efficiency, simplified process flow and reduced material expenses have been instrumental in lowering cost," said Paul Siblerud, EMC3D project director. "Today, fabs running iTSV can produce 3D-TSV devices at a total CoO of less than $150usd per wafer. Improved synchronization between the unit processes along with aggressive cost saving designs have been very successful at exceeding the consortium's original cost goals."

Sesh Ramaswami of Applied Materials said, "It has become clear that the larger diameter via-last pTSV used in DRAM, interposers and CIS devices have significantly different challenges than the smaller diameter high aspect ratio via-first iTSV structures. From etch and metallization, film stress management thru CMP and wafer bonding through debonding, these challenges require an integrated approach that EMC3D will focus on during this program extension."

"We are expanding our goal to include reliability improvements of both via-first (iTSV™) and via-last (pTSV™) processes," said Bioh Kim of EV Group. "Extending the roadmap to include a significantly reduced CoO to under $120usd per wafer will be a challenge, but one each member looks forward to working on."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.